CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... ·...
Transcript of CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... ·...
![Page 1: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/1.jpg)
CVD Prevention and Treatment During
Survivorship: What Lifestyle Changes and How?
Susan C. Gilchrist, MD, MS
Director, MD Anderson Healthy Heart Program
Associate Professor
Clinical Cancer Prevention & Cardiology
University of Texas MD Anderson Cancer Center
![Page 2: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/2.jpg)
Premature Accumulation of Risk Factors in Young Cancer Survivors
Tai, E. Cancer. 2012;118:4884–4891.
0
5
10
15
20
25
30
35
40
45
Smoker Binge
drinker
Obese No PA CVD HTN Disability DM
Risk behaviors Chronic conditions
Survivors of Adolescent and Young Adult Cancer Diagnosed at Ages 15 to 29 Years
Respondents Without a History of Cancer
%
![Page 3: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/3.jpg)
CV Risk Factors and Major CVD Events in Adult Survivors
of Childhood Cancer
Armstrong GT et al. JCO. 2013; 31:3673-3680.
2+ CV risk factors (RR, 2.4; 95% CI, 1.2 to 4.9)
![Page 4: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/4.jpg)
Causes of Accelerated CVD in Cancer Patients
Decreased Cardiovascular Reserve
SurgeryRadiation
Systemic Therapy
Physical inactivity / changes in body compositionAging
Other CVD risk factors (HTN)
CVRisk Factors
Cancer Diagnosis
Jones, LW. J Am Coll Cardiol. 2007;50:1435-1441.
Direct Effects
Indirect Effects
CVD
![Page 5: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/5.jpg)
Lifestyle and CVD Prevention in Cancer
![Page 6: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/6.jpg)
Exercise and Risk of Major CVD Events in Adult Survivors of
Hodgkin Lymphoma
Jones, LW. JCO. 2014; 32:3643-3650.
![Page 7: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/7.jpg)
Exercise and Survival After Breast Cancer
Ibrahim, EM. Med Oncol (2001) 28:753-765.
≥8 MET-hr-wk
≥ 15 MET-hr-wk
![Page 8: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/8.jpg)
Table 1: Systematic Reviews on the Effect of Exercise Training on VO2 in Cancer Patients (2005-2015)
Study Cancer Type Studies Reviewed
(studies measuring ∆ V02)
Timepoint of Intervention
(studies measuring ∆ V02)
Effect of ET on VO2
Singh et al.,
2013[66]
lung (61%), colorectal,
prostate, colon, pancreatic,
liver, colon, rectum,
sarcoma, esophagus
Systematic review of 18
clinical trials. (6)
Pre-surgical. ↑
Loughney et al.,
2015[101]
Breast (82%), lung, mixed Systematic review of 17
cliical trials. (4)
During cancer treatment. ↔
Schmitz et al.,
2005[68]
Breast (72%), colon, lung,
ovarian, leukemia,
lymphoma, testicular,
sarcoma, stomach,
prostate, other
Systematic review of 22
high-quality studies. (9)
During (5) and after (4)
cancer treatment.
↑ (weak evidence, during)
↑(strong evidence, after)
Jones et al.,
2011[102]
Breast (67%), lymphoma,
prostate, colon
Meta-analysis of 6 clinical
trials. (6)
During (2) and after (4)
cancer treatment.
↑
Wolin et al.,
2010[103]
Hematologic cancer
(100%)
Review of 23 high-quality
intervention studies in adults
and pediatric population.
Adults (1) Children (6)
Receiving and not receiving
hematopoietic stem cell
transplantation.
↑ (weak evidence, adults)
↑(strong evidence, children)
Fong et al.,
2012[72]
Breast (65%), colorectal,
endometrial, prostate,
lung, lymphoma, gastric,
colon, gynecologic
Meta-analysis of 34
randomized clinical trials.
(7)
After cancer treatment. ↑
Effects of Exercise Training on Fitness Across the Cancer
Continuum (2005-2015)
![Page 9: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/9.jpg)
A Cardiologist’s How To:
Exercise and Risk Factor Change in Cancer Patients
• When
– Prior to
treatment
– During
treatment
– Survivorship
• Where
– Physical therapy
– Oncology
rehabilitation
– Cardiac
rehabilitation
– Community centers
– Home-based
• How
– Referral
– Testing
– Exercise
prescriptions
![Page 10: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/10.jpg)
Cardiac Rehabilitation as a Model for
Cancer Patients
![Page 11: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/11.jpg)
Expanding Components of CR to Cancer Patients
Dalal, HM. BMJ. 2015; 351:h5000.
![Page 12: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/12.jpg)
PT consult
Flow to Cardiac Rehabilitation for Cancer Patients
Dittus, Lakoski et al. J Cardiopulm Rehabil Prev. 2015 Mar-Apr; 35(2): 130–139.
Complete
Chemotherapy
Trigger EPIC
consults
Cardiac Rehab
Cardiology
consult
Functional
evaluation
![Page 13: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/13.jpg)
Preventative Cardiology Consultation
• Goal of the consultation is to assess fitness and CVD risk factors
after cancer treatment.
• Provides patients with a personalized exercise routine.
• Patients also receive information regarding risk of heart disease and
ways to improve your heart health over a lifetime.
![Page 14: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/14.jpg)
Suggested Components of Consultation
• The patient’s evaluation will include a heart risk screening exam
and a treadmill exercise test.
• Impact of prior cancer treatment on heart health
• Fitness level
• Cholesterol levels
• Risk of hypertension or high blood pressure
• Risk of Diabetes
• Body weight and waist measurements
• Impact of family history on heart health
• Smoking cessation information, if needed
![Page 15: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/15.jpg)
Cardiopulmonary Exercise Testing
1. Measure VO2 -Cardiorespiratory Fitness2. Determine Cardiopulmonary Safety 3. Determine Exercise Dose4. Compare Fitness Level to Healthy Age-Sex
Matched Individuals5. Assess Etiology of Shortness of Breath
![Page 16: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/16.jpg)
Contraindications/Special Considerations Prior to Exercise in
Cancer Patients
Cardiac
Uncontrolled symptomatic heart failure
Acute myocarditis
Recent myocardial infarction
Severe symptomatic valvular disease
Uncontrolled heart rhythm
Acute pulmonary embolism
Severe hypertension (>200/110 mmHg)
Lab measures
Severe anemia (<8 g/dl)
Absolute neutrophil count <500
Platelet count <50 k/cmm
Symptoms
Severe shortness of breath
Acute nausea during exercise
Vomiting within 24 hours
Disorientation
Blurred vision
Other
Acute Infection
Acute metabolic disease
Unmanaged lymphedema
Mental or physical impairment to exercise
SPECIAL CONSIDERATIONS
Initial wound healing after surgery
Indwelling catheters
Bone and brain metastasis
Recent chemotherapy or radiation (within 24 hours)
![Page 17: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/17.jpg)
Aerobic Exercise Prescription During Rehabilitation
Intensity(% Max HR)
DurationFrequency
(# /wk)Steps perSession
Minutes per Week
Weeks 1–4 70-85% MHR*Increase from 20 to 30 minutes
Supervised: 2/wk Home: 1/wk
2000-30001.25 x baseline
60–90
Weeks 5–8 70-85% MHRIncrease from 30 to 40 minutes
Supervised: 2/wk Home: 1-2/wk
3000-45001.5 x baseline
120-160
Week 9–12 70-85% MHRContinue 40 minutes
Supervised: 2/wkHome: 2/wk
4500-50002 x baseline
160
* MHR = Maximum heart rate from baseline exercise tolerance test
Dittus, Lakoski et al. J Cardiopulm Rehabil Prev. 2015 Mar-Apr; 35(2): 130–139.
![Page 18: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/18.jpg)
Resistance Training Prescription During Rehabilitation
Upper Extremity Lower Extremity
Chest Quadriceps
Back Hamstrings
Shoulder Hip Flexors
Core Hip Extensors
Hip abduction
• The participant resistance training prescription will be based on their experience with resistance training and
modified for any identified range of motion deficits.
• Resistance exercise options targeting different muscle groups will be provided and selected based on initial testing
results.
• After initial oncology treatment the resistance training prescription is two sets of 8-12 repetitions, performed twice
weekly. The initial resistance for chest press and leg press will be set at 60-70% of 1RM for most participants.
Dittus, Lakoski et al. J Cardiopulm Rehabil Prev. 2015 Mar-Apr; 35(2): 130–139.
![Page 19: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/19.jpg)
Patient Example
• 27 year old survivor of AML
(diagnosed 7 years)
• Protocol CCG-2891 (included
anthracycline)
• Relapse
• Re-induction chemotherapy
• Stem Cell transplant 1997
• 2018 Echocardiogram: LVEF 53%
• Hypertension on Azor 10-40mg daily
– BP 120/78
• Insulin resistance on Metformin
– HbA1c 5.2%
• BMI 36 kg/m2
• Inconsistent exerciser
• Non-smoker
• No premature FH of CHD
• Cholesterol levels: LDL 153, HDL
34, TC 208
![Page 20: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/20.jpg)
Case Example: CPET
(26 year old male s/p treatment for AML)
![Page 21: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/21.jpg)
CVD Prevention Plan
• Blood Pressure
• Insulin resistance
• Cholesterol
• Exercise – Fitness
• Body Weight
• Psychosocial
![Page 22: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/22.jpg)
Conclusion
• CVD risk factor modification is key to preventing CVD in cancer
patients.
• Exercise improves fitness and survival among cancer patients.
• Cardiologists can leverage cardiac rehabilitation model to
systematically improve preventative and lifestyle modification for
cancer patients.
![Page 23: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/23.jpg)
![Page 24: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/24.jpg)
Questions
Question 1. A 70-year old woman treated with anthracycline-based
chemotherapy for a diagnosis of breast cancer 5 years ago has a 10-year
ASCVD risk of 10%. What is the recommended blood pressure target for
this woman with stage 1 hypertension?
1. <130/80
2. <140/90
3. <150/90
4. No blood pressure target
![Page 25: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/25.jpg)
Questions
Question 2: Exercise after a breast cancer diagnosis is associated with all
of the following except:
1. Improved quality of life
2. Reduced Fatigue
3. Improve Survival
4. Improved cardiorespiratory fitness
5. Reduction in breast cancer recurrence
![Page 26: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of](https://reader033.fdocuments.us/reader033/viewer/2022042309/5ed5a48d1b7fdd786a1b6512/html5/thumbnails/26.jpg)